Guffanti et al (2009) identified MALAT1 as an abundantly expressed lncRNA in breast tumours. Rare mutations were recently described in luminal breast cancer (Ellis et al, 2012). Clinical prognostic value of MALAT1 dysregulation in breast cancer is little known at this time (Xu et al, 2015). This evidence concerns the gene MALAT1 and breast carcinoma.